Phosphoric Acid

Phosphoric Acid

SCHEMBL3940342

CCCCOP(=O)(O)OCCCC.O=P(O)(O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.61
▸ LPAR3 Q9UBY5 8/20 0.58
▸ LPAR2 Q9HBW0 6/20 0.58
▸ LPAR1 Q92633 3/20 0.58
▸ TSHR P16473 1/20 0.46
▸ P2RY10 O00398 4/20 0.42
▸ GPR34 Q9UPC5 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29177519 0.97 CYP3A4 (0.64) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL15389152 0.97 CYP3A4 (0.64) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL26559 0.97 CYP3A4 (0.64) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL1498124 0.95 CYP3A4 (0.61) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL673594 0.95 CYP3A4 (0.61) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL12914744 0.95 CYP3A4 (0.61) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL9584742 0.95 CYP3A4 (0.61) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL6684785 0.95 CYP3A4 (0.61) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL9854018 0.95 CYP3A4 (0.61) CYP3A4LPAR3LPAR2LPAR1TSHR
SCHEMBL15232926 0.95 CYP3A4 (0.61) CYP3A4LPAR3LPAR2LPAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-26 — — US disclosed
US-11572430-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-02-07 — — US disclosed
US-11480877-B2 Resist composition, method for forming resist pattern, and polyphenol compound used therein MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-10-25 — — US disclosed
US-20220064137-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD, AND PURIFICATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-03-03 — — US disclosed
US-11256170-B2 Compound, resist composition, and method for forming resist pattern using it MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-02-22 — — US disclosed
US-11243467-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-02-08 — — US disclosed
CN-110914327-A Color-stable curing compositions comprising polyisocyanates of (cyclo) aliphatic diisocyanates 巴斯夫欧洲公司 2020-03-24 — — CN disclosed
US-7494762-B2 Positive resist composition for immersion lithography and method for forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2009-02-24 — — US disclosed
CN-100453620-C Flame retardant phosphonate additives for thermoplastic materials RHODIA (US) 2009-01-21 — — CN disclosed
EP-1115170-B1 NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY CELL AND METHOD FOR MANUFACTURING THE SAME PANASONIC CORP (JP) 2008-12-03 — — EP disclosed
US-20080090171-A1 POSITIVE RESIST COMPOSITION FOR IMMERSION LITHOGRAPHY AND METHOD FOR FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2008-04-17 — — US disclosed
CN-1833015-A Flame retardant phosphonate additives for thermoplastics RHODIA (US) 2006-09-13 — — CN disclosed
EP-1115170-A1 NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY CELL AND METHOD FOR MANUFACTURING THE SAME MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2001-07-11 — — EP disclosed
US-4895900-A ACRYLIC RESIN, PHOSPHOROUS ACID, EPOXY COMPOUND KANSAI PAINT COMPANY, LIMITED (JP) 1990-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11480877-B2 Resist composition, method for forming resist pattern, and polyphenol compound used therein SLC11A2, ABCC1, FBL CYP3A4 1997/4885LPAR3 2251/4885LPAR2 2476/4885
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin SLC39A11, CROCC, TERB1 CYP3A4 3096/4885LPAR3 1612/4885LPAR2 2337/4885
US-11256170-B2 Compound, resist composition, and method for forming resist pattern using it RDX, SLC11A2, FBL CYP3A4 2133/4885LPAR3 3441/4885LPAR2 3950/4885
US-11572430-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method C9, C5, C1R CYP3A4 1754/4885LPAR3 348/4885LPAR2 432/4885
US-20220064137-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD, AND PURIFICATION METHOD BCR, RER1, ASIC1 CYP3A4 1990/4885LPAR3 2679/4885LPAR2 2268/4885
US-11243467-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method C9, C5, C1R CYP3A4 1754/4885LPAR3 348/4885LPAR2 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback